Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-248749
Filing Date
2024-10-31
Accepted
2024-10-31 16:36:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d904482d424b5.htm 424B5 322983
2 EX-FILING FEES d904482dexfilingfees.htm EX-FILING FEES 18921
3 GRAPHIC g904482g00a01.jpg GRAPHIC 30360
4 GRAPHIC g904482g23x54.jpg GRAPHIC 53178
  Complete submission text file 0001193125-24-248749.txt   458384
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

EIN.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 424B5 | Act: 33 | File No.: 333-280117 | Film No.: 241415768
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)